Jay Shah ponders whether CDMO deals will revive next year to define pharma M&A.
PharmaThe exits you can expect to see in social care
Latest Features
Marion Jeng, associate at investment bank DAI Magister, identifies the femtech sectors healthcare investors should prioritise.
PR firm The PHA Group's Rob Scott-Collins describes how businesses can thrive in a prevention first world
Politics & policy